Trials / Completed
CompletedNCT01792713
Sertaconazole 2% Cream to Improve Symptoms Associated With Atopic Dermatitis
Randomisierte, Doppelblinde, Plazebo-kontrollierte Prüfung Zum Nachweis Der Wirksamkeit Und Der Lokalen Verträglichkeit Einer 2%Igen Sertaconazol-Crème Bei Patienten Mit Atopischer Dermatitis (Abridged)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 70 (actual)
- Sponsor
- Spirig Pharma Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Investigation aimed to explore the efficacy of a topical Sertaconazole cream 2% in patients with skin alterations associated with atopic dermatitis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sertaconazole 2% cream | |
| DRUG | Placebo |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2013-09-01
- Completion
- 2014-02-01
- First posted
- 2013-02-15
- Last updated
- 2015-05-20
Locations
2 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT01792713. Inclusion in this directory is not an endorsement.